The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.73

Today's change-0.13 -1.01%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.73

Today's change-0.13 -1.01%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc down (U.S.)$0.13

Allscripts Healthcare Solutions Inc closed lower Friday, dropping (U.S.)$0.13 or 1.01% to (U.S.)$12.73. Over the last five days, shares have gained 0.79%, but are down 17.23% for the last year to date. Shares have underperformed the S&P 500 by 17.97% during the last year.

Key company metrics

  • Open(U.S.) $12.84
  • Previous close(U.S.) $12.86
  • High(U.S.) $13.00
  • Low(U.S.) $12.60
  • Bid / Ask(U.S.) $11.12 / (U.S.) $0.00
  • YTD % change-17.23%
  • Volume1,466,715
  • Average volume (10-day)2,197,259
  • Average volume (1-month)2,397,831
  • Average volume (3-month)2,351,662
  • 52-week range(U.S.) $11.47 to (U.S.) $15.78
  • Beta1.09
  • Trailing P/E866.58×
  • P/E 1 year forward21.65×
  • Forward PEG1.34×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.02
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.78%

Based on its net profit margin of 0.78%, Allscripts Healthcare Solutions Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.06%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue387346346354
Total other revenue--------
Total revenue387346346354
Gross profit167152154153
Total cost of revenue220194192201
Total operating expense368334323346
Selling / general / administrative95847991
Research & development48474648
Depreciation / amortization5446
Interest expense (income), net operating--------
Unusual expense (income)0510
Other operating expenses, total--------
Operating income1912239
Interest income (expense), net non-operating-12-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-3315-1
Income after tax-2216-5
Income tax, total-11-24
Net income-2216-5
Total adjustments to net income-8------
Net income before extra. items-2216-5
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10216-5
Inc. avail. to common incl. extra. items-10216-5
Diluted net income-10216-5
Dilution adjustment00----
Diluted weighted average shares187191189189
Diluted EPS excluding extraordinary itemsvalue per share-0.050.010.09-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.050.030.09-0.03